In conclusion, this study revealed that non-toxic doses of statins could markedly potentiate the activity of aminopeptidase inhibitor (APi) drugs; both direct inhibitors like Bestatin and APi prodrugs like CHR2863 to (drug-resistant) human acute myeloid leukemia (AML) cells. Here, CPQ is linked to acute myeloid leukemia.